Schroder Investment Management Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Sell |
310,891
-34,707
| -10% | -$1.15M | 0.01% | 632 |
|
|
2025
Q1 | $14.9M | Buy |
345,598
+196,165
| +131% | +$8.47M | 0.02% | 572 |
|
|
2024
Q4 | $7.05M | Buy |
149,433
+13,708
| +10% | +$646K | 0.01% | 712 |
|
|
2024
Q3 | $7.17M | Sell |
135,725
-117,762
| -46% | -$6.22M | 0.01% | 728 |
|
|
2024
Q2 | $13.7M | Hold |
253,487
| – | – | 0.02% | 569 |
|
|
2024
Q1 | $17.8M | Buy |
253,487
+142,340
| +128% | +$9.98M | 0.02% | 520 |
|
|
2023
Q4 | $9.28M | Buy |
+111,147
| New | +$9.28M | 0.01% | 646 |
|